Sildenafil Tablet, Film Coated
Product Images NDC 72162-2363

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 72162-2363). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Camber1 (Camber1)

Camber1 (Camber1)
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This is a list of interacting drugs, including Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir. The text also provides information on recommended dose adjustments and coadministration suggestions based on fold change and 90% confidence intervals. The data includes AUC (Area Under the Curve) and Cmax (maximum concentration) values, as well as statements like "No dose adjustment recommended" and "Coadministration not recommended". The information is important for understanding potential drug interactions.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
The text provided contains a list of interacting drugs, including Acenocoumarol, Aspirin, Atorvastatin, Bosentan, and others. It also mentions possible interactions and recommendations for dose adjustments or coadministration. The text includes information on fold change and confidence intervals, and a note on the lack of exercise capacity benefits when sildenafil is added to bosentan therapy. Lastly, a caution is given regarding the effect of ritonavir on sildenafil pharmacokinetics.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
This text appears to be a partial data table showing the results of a study evaluating the percentage of participants without a certain adverse event over time (in days) from randomization. The data includes values for Placebo and Sildenafil treatments. Unfortunately, the complete context or purpose of the study is not clear from this extracted text.*
FDA Label Image

Label (Lbl721622363)

Label (Lbl721622363)
This is a description of a medication containing Sildenafil Citrate. Each film-coated tablet contains 20 mg of Sildenafil Citrate. The medication should be stored between 20°C to 25°C (68°F to 77°F) and kept out of reach of children. It should be dispensed in a tight, light-resistant container. The typical adult dosage information can be found in the package insert available at www.dailymed.nlm.nih.gov. Manufacturer information and National Drug Code (NDC) are also provided on the label.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.